BASKING RIDGE, N.J., November 13, 2024--(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) will highlight new clinical research and ...
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
8316.T Sumitomo Mitsui Financial Group, Inc.
Jinhuei Enya Dai is a practitioner and researcher who believes that pedagogy is theory in practice, and has dedicated herself to innovative pedagogy, an ecological perspective, content-based ...
Plus, news about Disc Medicine, AlloVir, Kalaris, Travere Therapeutics and Trevena: Daiichi Sankyo, Alteogen to develop subcutaneous version of Enhertu: Daiichi will pay $20 million upfront to the ...
GD&TĐ - Giáo dục Thủ đô phải hướng tới là nền giáo dục thanh lịch; trong đó trường học là trường học thanh lịch, thầy cô và học sinh thanh lịch. GD&TĐ - Chiều 12/11, sau 3 phiên đăng đàn của 3 thành ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback